Tracking outcomes after heart rhythm procedures in Düsseldorf.
Registry on Electrophysiological Studies (EPS) at University Hospital Düsseldorf
This registry collects information to see how safe and effective routine electrophysiology procedures (like catheter ablation and cardioversion) are for people treated for AF, atrial flutter, supraventricular tachycardias, or VT at University Hospital Düsseldorf.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Heinrich-Heine University, Duesseldorf Academic / other |
| Locations | 1 site (Düsseldorf) |
| Trial ID | NCT07196176 on ClinicalTrials.gov |
What this trial studies
This single-center registry at University Hospital Düsseldorf systematically collects retrospective and prospective clinical data on adults undergoing electrophysiological studies, catheter ablation, or electrical cardioversion. It records demographics, comorbidities, laboratory and imaging results, procedural details, and follow-up outcomes with scheduled visits at 1, 3, 6, 12, and 24 months and additional phone follow-up as needed. Primary endpoints focus on procedural safety (peri- and postprocedural complications, late adverse events) and efficacy (arrhythmia recurrence, repeat procedures, pacemaker implantation, or new medications), with secondary endpoints including hospitalization and all-cause mortality. Participation does not change routine diagnostic or therapeutic decisions and involves no additional invasive procedures.
Who should consider this trial
Good fit: Adults (≥18) who undergo an electrophysiological study, catheter ablation, or electrical cardioversion at University Hospital Düsseldorf and, for the prospective arm, provide written informed consent.
Not a fit: Patients under 18, pregnant individuals, or people treated at other hospitals are unlikely to benefit directly from this registry's findings, and participants should not expect immediate personal treatment benefit from enrollment.
Why it matters
Potential benefit: If successful, this registry could help make heart rhythm procedures safer and more effective by identifying patient- and procedure-related factors that predict complications and treatment success.
How similar studies have performed: Similar large electrophysiology registries have previously provided useful safety and outcome data, so this approach is established rather than novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who undergo an electrophysiological study (EPS) or electrical cardioversion at University Hospital Düsseldorf since 2015 (retrospective cohort) * Patients scheduled to undergo an EPS or electrical cardioversion at University Hospital Düsseldorf from 2019 onward (prospective cohort) •- Written informed consent for participation in the registry (prospective part only) Exclusion Criteria: * \< 18 years * Lack of written informed consent * Pregnancy
Where this trial is running
Düsseldorf
- University Hospital Duesseldorf — Düsseldorf, Germany (Recruiting)
Study contacts
- Principal investigator: Obaida Rana, MD — Division of Cardiology, Pulmonary Disease and Vascular Medicine at University Hospital Duesseldorf
- Study coordinator: Obaida Rana, MD
- Email: obaida.rana@med.uni-duesseldorf.de
- Phone: +492118118800
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.